Barry Kramer

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?

Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2slope and peak VO2

Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy New markers of exercise intolerance with clinical implications

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles

Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: Detection by cardiac troponins

Evaluation of Diastolic Filling of Left Ventricle in Health and Disease: Doppler Echocardiography Is the Clinician’s Rosetta Stone

Universal Definition of Myocardial Infarction

Management of Patients Undergoing Percutaneous Coronary Revascularization

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

Calcium's Role in Mechanotransduction during Muscle Development

The Failing Heart — An Engine Out of Fuel

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Ventilatory Efficiency and Resting Hemodynamics in Hypertrophic Cardiomyopathy

Prognosis of congestive heart failure and predictors of mortality

Serial exercise testing and prognosis in selected patients considered for cardiac transplantation

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Percutaneous Repair or Surgery for Mitral Regurgitation

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients

The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization

Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors

Retrieval and analysis of particulate debris after saphenous vein graft intervention

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT)

The prognostic value of body mass index and standard exercise testing in male Veterans with congestive heart failure

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Chronic Aortic Regurgitation: Indications for Operation—1988

Prognosis determination in heart failure

Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure

Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril

Prognostic Significance and Measurement of Exercise-Derived Hemodynamic Variables in Patients With Heart Failure

Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.

Effects of Endurance Training on Mitochondrial Ultrastructure and Fiber Type Distribution in Skeletal Muscle of Patients With Stable Chronic Heart Failure

Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation

Contribution of peak respiratory exchange ratio to peak VO2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure

Cardiac Resynchronization in Chronic Heart Failure

The Clinical Course of Pulmonary Embolism

Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure

Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay

Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

Effects of Gender on Peak Oxygen Consumption and the Timing of Cardiac Transplantation

Ease of Noninvasive Measurement of Cardiac Output Coupled With Peak VO2 Determination at Rest and During Exercise in Patients With Heart Failure

Three-year follow-up of the argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI)

Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults

Burden of valvular heart diseases: a population-based study

Myonecrosis After Revascularization Procedures

Peri-procedural myocardial injury: 2005 update

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Development and validation of a simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice

Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure

Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy

Ventilatory mechanisms of exercise intolerance in chronic heart failure

Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation

Clinical Perspectives

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope

The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

Effects of exercise training in patients with congestive heart failure: A critical review

Predicting Mortality Among Patients Hospitalized for Heart Failure

Chronic Aortic Insufficiency: Factors Associated with Progression to Aortic Valve Replacement

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training

Exercise limitation in chronic heart failure: Central role of the periphery

Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients

Biomarkers in Heart Failure

Burden of Systolic and Diastolic Ventricular Dysfunction in the Community

Bias in meta-analysis detected by a simple, graphical test

What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.

The Progression From Hypertension to Congestive Heart Failure

Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure

Recommendations on the use of exercise testing in clinical practice

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.

Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention

Significance of Mild Transient Release of Creatine Kinase–MB Fraction After Percutaneous Coronary Interventions

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function.

Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.

Exercise Capacity and Mortality among Men Referred for Exercise Testing

Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure

Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Clinical End Points in Coronary Stent Trials

Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure

Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification

Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

Heart Rate Variability

Experience with the Preoperative Invasive Measurement of Haemodynamic, Respiratory and Renal Function in 100 Elderly Patients Scheduled for Major Abdominal Surgery

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention

Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS)

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Hemodynamic Exercise Testing

Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy

Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty?

Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: A multicenter experience

Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty

Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: Relation to simultaneous hemodynamic measurements

Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

Long-term captopril therapy for chronic congestive heart failure

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

Two-dimensional echocardiographic evaluation of the size, function and shape of the left ventricle in chronic aortic regurgitation: Comparison with radionuclide angiography